Monday, 4 December 2017

CVS Aetna Deal Tests Positive

A significant potential to re-energize the pharmacy business justifies the $69 billion price tag.

from WSJ.com: Markets http://ift.tt/2jehtFi
via https://ifttt.com/ IFTTT

No comments:

Post a Comment